INSMED (INSM) Gains from Sales and Divestitures: 2013-2014
Historic Gains from Sales and Divestitures for INSMED (INSM) over the last 2 years, with Sep 2014 value amounting to $91,939.
- INSMED's Gains from Sales and Divestitures fell 37.83% to $91,939 in Q3 2014 from the same period last year, while for Sep 2014 it was $91,939, marking a year-over-year decrease of 37.83%. This contributed to the annual value of $177,316 for FY2013, which is N/A change from last year.
- Latest data reveals that INSMED reported Gains from Sales and Divestitures of $91,939 as of Q3 2014, which was down 0.00% from $91,939 recorded in Q2 2014.
- INSMED's Gains from Sales and Divestitures' 5-year high stood at $177,316 during Q4 2013, with a 5-year trough of $68,803 in Q1 2013.
- Moreover, its 2-year median value for Gains from Sales and Divestitures was $91,939 (2014), whereas its average is $116,094.
- Within the past 5 years, the most significant YoY rise in INSMED's Gains from Sales and Divestitures was 33.63% (2014), while the steepest drop was 37.83% (2014).
- INSMED's Gains from Sales and Divestitures (Quarterly) stood at $177,316 in 2013, then tumbled by 37.83% to $91,939 in 2014.
- Its last three reported values are $91,939 in Q3 2014, $91,939 for Q2 2014, and $91,939 during Q1 2014.